Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver Disease
Contrast-enhanced Ultrasound (CEUS) Improves Characterization of Atypical Liver Nodules in Patients With Chronic Liver Disease
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A observational or N/A phase clinical study on Hepatocellular Carcinoma, this trial is completed. The trial is conducted by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and has accumulated 3 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
First recorded
Aug 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
For direct contact, visit the study record on ClinicalTrials.gov .